This Article Full Text Full Text (PDF) Supplementary Data Correction (v68,p626) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nefedova, Y. Articles by Gabrilovich, D. I. Search for Related Content PubMed PubMed Citation Articles by Nefedova, Y. Articles by Gabrilovich, D. I.

Mechanism of All-Trans Retinoic Acid Effect on Tumor-Associated Myeloid-Derived Suppressor Cells

¹ H. Lee Moffitt Cancer Center and University of South Florida, Tampa, Florida and ² University of Nebraska Medical Center, Omaha, Nebraska

Requests for reprints: Dmitry I. Gabrilovich, H. Lee Moffitt Cancer Center, MRC 2067, 12902 Magnolia Drive, Tampa, FL 33612. Phone: 813-903-6863; Fax: 813-745-1328; E-mail: dmitry.gabrilovich{at}moffitt.org.

Myeloid-derived suppressor cells (MDSC) play an important role in tumor escape by suppressing T-cell responses. MDSC represent a group of cells of myeloid lineage at different stages of differentiation. Increased arginase activity and production of reactive oxygen species (ROS) are among the main functional characteristics of these cells. Recent studies have shown that all-trans retinoic acid (ATRA) had a potent activity in eliminating MDSC in cancer patients and in tumor-bearing mice. ATRA differentiates these cells into mature myeloid cells. However, the mechanism of this effect is unclear. Here, we have shown that ATRA dramatically and specifically up-regulated gene expression and protein level of glutathione synthase (GSS) in MDSC. This resulted in accumulation of glutathione (GSH) in these cells, observed in both mice and cancer patients. Blockade of GSH synthesis cancelled the effect of ATRA on MDSC. Accumulation of GSH in these cells using N-acetyl-L-cysteine mimicked the effect of ATRA on MDSC differentiation. Analysis of potential mechanisms of ATRA effect on GSS revealed that ATRA regulates its expression not by directly binding to the promoter but primarily via activation of extracellular signal–regulated kinase 1/2. Thus, ATRA induced differentiation of MDSC primarily via neutralization of high ROS production in these cells. This novel mechanism involves specific up-regulation of GSS and accumulation of GSH and could be used in developing and monitoring therapeutic application of ATRA. [Cancer Res 2007;67(22):11021–8]

This article has been cited by other articles:

				R. D. Winfield, M. J. Delano, K. Pande, P. O. Scumpia, D. LaFace, and L. L. Moldawer Myeloid-Derived Suppressor Cells in Cancer Cachexia Syndrome: A New Explanation for an Old Problem JPEN J Parenter Enteral Nutr, November 1, 2008; 32(6): 651 - 655. [Abstract] [Full Text] [PDF]

				D. M. Heithoff, E. Y. Enioutina, D. Bareyan, R. A. Daynes, and M. J. Mahan Conditions That Diminish Myeloid-Derived Suppressor Cell Activities Stimulate Cross-Protective Immunity Infect. Immun., November 1, 2008; 76(11): 5191 - 5199. [Abstract] [Full Text] [PDF]

				Correction: MDSC and ATRA Cancer Res., January 15, 2008; 68(2): 626 - 626. [Full Text] [PDF]